Viewing Study NCT03278132


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-01-02 @ 11:41 AM
Study NCT ID: NCT03278132
Status: COMPLETED
Last Update Posted: 2019-01-02
First Post: 2017-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine
Sponsor: Sinovac Biotech Co., Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hand, Foot and Mouth Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Inactivated Enterovirus Type 71 (EV71) Vaccine View
None Safety View
None Immunogenicity View
None Infant View